Good news! Jiangsu Macro & Micro-Test Med-Tech Co.,Ltd. will create more brilliant achievements!
Recently, SARS-CoV-2/influenza A /influenza B Nucleic Acid Combined Detection Kit (Fluorescence PCR) independently developed by Macro & Micro-Test were successfully approved by Indonesian AKL. This breakthrough achievement is an important milestone for Macro & Micro-Test to reach a new peak in the field of health prevention and control!
The respiratory tract triple test kit is an innovative product created by Macro & Micro-Test for the current global health prevention and control needs. The kit uses advanced molecular diagnosis technology, which can simultaneously detect nucleic acids of novel coronavirus, influenza A virus and influenza B virus, with high sensitivity, high specificity and high accuracy. In a short time, the kit can accurately and quickly detect virus nucleic acid, which provides strong support for health prevention and control.
With the approval of Indonesian AKL, the kit will be widely used in the detection of nasopharyngeal swab and oropharyngeal swab in patients with suspected pneumonia, suspected clustering cases and other people who need to be diagnosed or differentiated with novel coronavirus infection. This innovative product will help to find and isolate infected people in time, control the spread of the virus and protect public health!
We sincerely congratulate Macro & Micro-Test on this major breakthrough, and expect the company to continue to create more brilliant achievements in the field of medical science and technology in the future, and make greater contributions to the global human health cause!
Post time: Dec-12-2023